Integrated Diagnostics Holdings plc (IDGXF)

Market Cap	287.76M
Revenue (ttm)	136.41M
Net Income (ttm)	22.15M
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	12.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	24,012
Open	0.3200
Previous Close	0.3220
Day's Range	0.3200 - 0.3200
52-Week Range	0.2830 - 0.4720
Beta	0.22
RSI	58.98
Earnings Date	Sep 2, 2025

About IDGXF

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDGXF

Financial Performance

In 2024, IDGXF's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP